VS
Vikas Sharma
About Vikas Sharma
Data last updated:
Vikas Sharma is a Whole-Time Director at Acme Formulation Private Limited (since 2020), Whole-Time Director at Acme Generics Private Limited (since 2021) and Whole-Time Director at Immacule Lifesciences Private Limited (since 2021), and holds 2 more current directorships. The companies operate in Pharma, Chemicals and Financial Services. The 5 current companies with reported revenue have a combined latest revenue of ₹987 Cr; the largest is Acme Formulation Private Limited at ₹577 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 29 Jul 2020 | 2004 | ₹577 Cr (FY 2025) | Active | |
| Whole-Time Director | 05 Aug 2021 | 2021 | ₹264 Cr (FY 2024) | Active | |
| Whole-Time Director | 31 Aug 2021 | 2010 | ₹143 Cr (FY 2025) | Active | |
| Director | 30 Sep 2021 | 2013 | ₹2.03 Cr (FY 2025) | Active | |
| Director | 30 Sep 2021 | 2009 | ₹1.03 Cr (FY 2025) | Active |
Board colleagues of Vikas Sharma
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aswin Vikram | 08895013 | Acme Formulation Private Limited | Director |
| Ginny Uppal | Acme Formulation Private Limited , Acme Generics Private Limited and 3 more | Company Secretary | |
| Nikhil Kumar Srivastava | 07308617 | Acme Formulation Private Limited | Director |
| Viral Shah | 01079170 | Acme Formulation Private Limited , Acme Generics Private Limited and 3 more | Managing Director |
| Viral Shah | Immacule Lifesciences Private Limited | Ceo |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vikas Sharma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vikas Sharma
Vikas Sharma currently holds 5 directorships: Acme Formulation Private Limited (Whole-Time Director, since 29 Jul 2020, revenue ₹577 Cr (FY 2025)); Acme Generics Private Limited (Whole-Time Director, since 05 Aug 2021, revenue ₹264 Cr (FY 2024)); Immacule Lifesciences Private Limited (Whole-Time Director, since 31 Aug 2021, revenue ₹143 Cr (FY 2025)); Ace Invest Private Limited (Director, since 30 Sep 2021, revenue ₹2.03 Cr (FY 2025)); Ace Testing Solutions Private Limited (Director, since 30 Sep 2021, revenue ₹1.03 Cr (FY 2025)).
Vikas Sharma was first appointed on 29 Jul 2020 as Whole-Time Director at Acme Formulation Private Limited. The most recent appointment on record is 30 Sep 2021 at Ace Testing Solutions Private Limited.
The 5 current companies of Vikas Sharma that report revenue have a combined latest revenue of ₹987 Cr: Acme Formulation Private Limited ₹577 Cr (FY 2025); Acme Generics Private Limited ₹264 Cr (FY 2024); Immacule Lifesciences Private Limited ₹143 Cr (FY 2025); Ace Invest Private Limited ₹2.03 Cr (FY 2025); Ace Testing Solutions Private Limited ₹1.03 Cr (FY 2025).
The current boards of Vikas Sharma's companies include Aswin Vikram (Acme Formulation Private Limited), Ginny Uppal (Acme Formulation Private Limited), Nikhil Kumar Srivastava (Acme Formulation Private Limited), Viral Shah (Acme Formulation Private Limited), Viral Shah (Immacule Lifesciences Private Limited).